Sign in to continue:

Tuesday, February 24th, 2026

Abundia Global Impact Group Announces $20 Million Registered Direct Offering to Fund Low-Carbon Energy Projects

Abundia Global Impact Group Announces \$20 Million Registered Direct Offering to Accelerate Growth Initiatives

Key Highlights

  • Houston-based low-carbon energy company, Abundia Global Impact Group, Inc. (NYSE: AGIG), has announced the pricing of a \$20 million registered direct offering of common stock.
  • The offering involves the sale of 5,934,718 shares of common stock (or pre-funded warrants in lieu thereof), purchased by a new fundamental institutional investor.
  • Gross proceeds are expected to be approximately \$20 million, before deducting offering expenses.
  • The closing of the offering is anticipated on or about February 23, 2026, subject to customary closing conditions.
  • Titan Partners, a division of American Capital Partners, is acting as the sole placement agent for the offering.

Details Investors Need to Know

  • Use of Proceeds: The Company plans to utilize the net proceeds for several strategic initiatives:
    • Completing the Front-End Engineering and Design (FEED) study
    • Finalizing the acquisition of RPD Technologies
    • Reducing company debt
    • Initiating construction of an innovation hub
    • General corporate purposes and working capital
  • Milestone Financing: CEO Ed Gillespie emphasized that this financing is a significant milestone for Abundia, as it is expected to fully fund key near-term objectives, including the FEED study, RPD Technologies acquisition, and the innovation hub’s development. These initiatives are described as “critical value inflection points” that can drive scalable, long-term growth.
  • Offering Structure: The registered direct offering is being made under an effective shelf registration statement on Form S-3 (File No. 333-290308), previously filed and approved by the SEC. The offering is only being made by means of a prospectus supplement filed with the SEC.
  • Company Overview: Abundia Global Impact Group, Inc., formerly Houston American Energy Corp., is focused on converting waste plastics and biomass into drop-in fuels and low-carbon chemical feedstocks. Its flagship Cedar Port project is strategically located on the Gulf Coast, providing access to essential supply chains, partners, and markets.

Potentially Price-Sensitive Information for Shareholders

  • This \$20 million capital raise, with participation from a new institutional investor, enhances Abundia’s liquidity and provides funding to reach important operational and strategic milestones. This could positively affect the company’s share value by de-risking its near-term objectives and accelerating commercial deployment.
  • Proceeds will be used to reduce debt, which may improve the company’s financial stability and credit profile.
  • The completion of the FEED study and the RPD Technologies acquisition are expected to be key catalysts for future growth and value creation, making this development potentially significant for both current and prospective shareholders.
  • Risks & Forward-Looking Statements: The Company reminds investors that forward-looking statements are subject to risks including, but not limited to, liquidity constraints, the need for additional financing, ability to continue as a going concern, maintaining NYSE listing, and predicting growth rates. These risks and uncertainties can materially affect actual results.

Additional Information

  • For further details, investors can access the prospectus supplement and company filings on the SEC website.
  • Abundia’s investor relations can be contacted at [email protected] via CORE IR.

Disclaimer: This article is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities of Abundia Global Impact Group, Inc. The information herein contains forward-looking statements that involve risks and uncertainties that may cause actual results to differ materially from those anticipated. Investors should conduct their own due diligence and consult with their financial advisor before making investment decisions. Please refer to the company’s filings with the SEC for a complete discussion of risks and uncertainties.

View ABUNDIA GLOBAL IMPACT GROUP, INC. Historical chart here



Corcept Therapeutics Provides Update on Patent Dispute With Teva Pharmaceuticals Over Korlym Generic – Court Rules No Infringement

Key Points from the Report Federal Court Ruling: The United States Court of Appeals for the Federal Circuit has upheld a previous verdict that Teva Pharmaceuticals’ marketing of a generic version of Korlym® does...

Hims & Hers Health, Inc. 2025 Annual Report: Business Overview, Growth Strategy, and Regulatory Environment

Hims & Hers Health, Inc. (HIMS) 2025 Annual Report: Key Investor Insights Hims & Hers Health, Inc. (HIMS) 2025 Annual Report: Key Investor Insights Highlights from the 2025 Annual Report Fiscal Year End: December...

Omnicom 2025 Annual Report: Business Overview, AI Integration, Risk Factors, and Cybersecurity Strategy

Omnicom Group Inc. Annual Report 2025: Investor Analysis Omnicom Group Inc. Annual Report 2025: Key Updates, Risks, and Investor Implications Executive Summary Omnicom Group Inc., a leading global marketing and communications company, has released...

   Ad